Arcus Biosciences, Inc. (NYSE:RCUS) Q4 2025 Earnings Call Transcript
Arcus Biosciences, Inc. (NYSE:RCUS) Q4 2025 Earnings Call Transcript February 25, 2026 Arcus Biosciences, Inc. beats earnings expectations. Reported EPS is $-0.89, expectations were $-1.11. Operator: Hello, everyone, and thank you for joining the Arcus …